Tough day, every stock posted on Traders fell, one 26% and

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 2

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Midea's VitaBreeze: Revolutionizing Personalized Climate

Updated Category News Views 7

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 13

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 2

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading
FDI Launches 'Generation Smile' for Global Oral Health

Updated Category News Views 4

A New Kind of Movement Imagine a campaign not bound by age or geography but united by a shared mission. Generation Smile, freshly launched by the FDI World Dental Federation in Prague, is just that kind of uprising. This initiative redefines existing approaches to oral health, pushing beyond the boundaries of mere dental care to emphasize the integral role oral health...

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 2

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 3

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading

Top 5 Most Recently Viewed Articles

Ameritas Honors Galli, Pantozzi in Hall of Fame

Updated Category News Views 10

Two Titans of Finance Recognized by Ameritas When you've been around the block as many times as Dan Galli and Joe Pantozzi, you've seen a lot go down in the insurance trenches. And this time, they're not just getting another plaque to stash in some dusty boardroom corner; they're stepping into the Ameritas Hall of Fame. That Hall ain't just for anyone—it's reserved for...

Continue Reading
Kornit Digital Unveils Innovative Footwear Solution for Athleisure

Updated Category News Views 136

Kornit Digital's Footwear Solution: A Game-Changer in Production Kornit Digital Ltd. (NASDAQ: KRNT), a leader in sustainable digital textile production, has introduced a revolutionary footwear solution designed for the sports and athleisure markets at ITMA Asia + CITME Singapore 2025. This launch signifies a monumental advancement in digital production, establishing...

Continue Reading
Innovative Partnership to Enhance AI-Driven Leukemia Treatments

Updated Category News Views 361

Groundbreaking Collaboration in Leukemia Care In an exciting development for personalized medicine, Biostate AI, a notable leader in RNA sequencing artificial intelligence, has forged a strategic partnership with Weill Cornell Medicine. This pioneering collaboration aims to harness advanced AI technology to enhance the management of leukemia, focusing particularly on...

Continue Reading
Expensify CFO Engages in Notable Stock Transactions Amid Growth

Updated Category News Views 148

Expensify CFO Executes Noteworthy Stock Sales Expensify, Inc. (NASDAQ: EXFY) has recently experienced some interesting financial activities coming from its Chief Financial Officer, Ryan Schaffer. According to a recent SEC filing, Schaffer sold a substantial portion of the company’s Class A Common Stock, amounting to over $8,600, as part of a series of transactions....

Continue Reading
VoltServer Launches Solution Partner Program for Digital Electricity®

Updated Category News Views 134

VoltServer Introduces Innovative Solution Partner Program VoltServer is at the forefront of revolutionizing power distribution with its cutting-edge Digital Electricity® technology. Their newly launched Solution Partner Program aims to collaborate with leading organizations committed to innovation in the power sector. This program seeks to facilitate better integration...

Continue Reading